Top Menu
  • Doctors
  • Locations
  • About
  • Financial Advocacy
  • Articles/News
  • Contact
  • Patient Portal
  • Make A Payment
Regional Cancer Care Associates
Call (844) 346-7222 Contact Us
Main Menu
  • Navigating Care
    • Getting Started
    • Oncology Medical Home
    • Cancer Types
    • Services
    • Clinical Trials
    • Side Effects Management
    • Cancer Care Support
    • Financial Advocacy
    • Patient & Caregiver Education
  • Cancer Types
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Cervical Cancer
    • Colon Cancer
    • Esophageal Cancer
    • Fallopian Tube Cancer
    • Head & Neck Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Mesothelioma
    • Multiple Myeloma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Rectal Cancer
    • Skin Cancer
    • Stomach Cancer
    • Testicular Cancer
    • Thyroid Cancer
    • Uterine Cancer
  • Services
    • Chemotherapy
    • Immunotherapy
    • Targeted Therapy
    • Radiation Therapy
    • Hematology
    • Clinical Trials
    • Radiosurgery
    • Surgery
    • Genetic Testing
    • Palliative Care
    • Integrative Care
    • Pharmacy
    • Hospital Consultation
    • Blood & Marrow Stem Cell Transplantation
  • Clinical Trials
    • All Clinical Trials
  • For Providers
    • Care Coordination
    • Oncology Medical Home
    • Imaging Guidelines
rcca-header
Cancer Type: Neuro-Oncology

A Phase 3, Randomized, Double blind, Placebo controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination with Acalabrutinib (ACP 196) in Subjects with Previously Untreated Mantle Cell Lymphoma

Expanded Access (Compassionate Use) Treatment Protocol: Rindopepimut (CDX-110)

Neuro-Oncology Database

Retrospective review of patients with recurrent glioblastoma multiforme (GBM) treated with ipilimumab)

A Phase II, Multicenter, Open-Label, Single Arm Study to Evaluate the Safety, Tolerability, and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

Pilot Study of NovoTTF in Conjunction with Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab Versus Bevacizumab Alone in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma

Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) with Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

  • 1
  • 2
  • Next »

Find a Location

View All Locations


Find a Doctor

View All Doctors

Recent & Upcoming Events

  • “Look Good …Feel Better”
  • Watch Dr. Fang’s presentation “What’s New in Lung Cancer?”
  • Advances in Breast Cancer and New Developments

Recent News

  • African Americans And Cancer Risk – Test Your Knowledge: A Conversation with RCCA’s Dr. Seth Howard Berk March 28, 2018
  • Ovarian Cancer – What We Know Today About Risk Factors and Early Detection: A Conversation with RCCA’s Dr. Kenneth D. Nahum April 15, 2018
  • Testicular Cancer: Detection, Symptoms and Treatment March 21, 2018
Regional Cancer Care Associates
Corporate Office
25 Main Street, Suite 601
Hackensack, NJ 07601
Phone: (844) 346-7222
Fax: (201) 546-7892
info@regionalcancercare.org
  • About
  • Doctors
  • RCCA Management
  • RCCA Board
  • Locations
  • Events
  • Contact
  • For Providers
  • Careers
  • Notice of Privacy Practices
  • Privacy Policy

Find a Doctor

Find a Location

Facebook Twitter Youtube LinkedIn
© 2018 Regional Cancer Care Associates. All rights reserved. | Website by Healthcare Success.